Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2454)
All Articles published online
|
Apr 15, 2002 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guan XJ, Guan XJ, Wu YZ, Jia ZC, Shi TD, Tang Y. Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine. World J Gastroenterol 2002; 8(2): 294-297 [PMID: 11925610 DOI: 10.3748/wjg.v8.i2.294] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/294.htm |
| Number | Citing Articles |
| 1 |
Chuan-Lin Ding, Kun Yao, Tian-Tai Zhang, Feng Zhou, Lin Xu, Jiang-Ying Xu. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells. World Journal of Gastroenterology 2003; 9(7): 1512-1515 doi: 10.3748/wjg.v9.i7.1512
|
| 2 |
De-Wei Du, Zhan-Sheng Jia, Guang-Yu Li, Yong-Ying Zhou. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. World Journal of Gastroenterology 2003; 9(1): 108-111 doi: 10.3748/wjg.v9.i1.108
|
| 3 |
Erica L. Woodahl, Rodney J. Y. Ho. Cellular Drug Delivery. 2004; : 45 doi: 10.1007/978-1-59259-745-1_4
|
| 4 |
Åsa Schiött, Kristina Larsson, Søren Manniche, Suzanne Kalliomäki, Annette Vinther Heydenreich, Kristian Dalsgaard, Nikolai Kirkby. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. International Journal of Pharmaceutics 2011; 414(1-2): 312 doi: 10.1016/j.ijpharm.2011.05.026
|
| 5 |
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Wei Zhou, Li-Yun Zou. Therapeutic polypeptides based on HBcAg<sub>18-27</sub> CTL epitope can induce antigen-specific CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2 transgenic mice. World Journal of Gastroenterology 2004; 10(8): 1222-1226 doi: 10.3748/wjg.v10.i8.1222
|
| 6 |
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Li-Yun Zou, Wei Zhou. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2<sup>+</sup> human PBMCs. World Journal of Gastroenterology 2004; 10(13): 1902-1906 doi: 10.3748/wjg.v10.i13.1902
|
| 7 |
Hong Cheng, Hui-Zhong Zhang, Wan-An Shen, Yan-Fang Liu, Fu-Cheng Ma. Expression of RNase H of human hepatitis B virus polymerase in <italic>Escherichia coli</italic>. World Journal of Gastroenterology 2003; 9(3): 513-515 doi: 10.3748/wjg.v9.i3.513
|
| 8 |
Megan T Sanders, Lorena E Brown, Georgia Deliyannis, Martin J Pearse. ISCOMTM‐based vaccines: The second decade. Immunology & Cell Biology 2005; 83(2): 119 doi: 10.1111/j.1440-1711.2005.01319.x
|
| 9 |
Rishi Paliwal, Shivani R Paliwal, Suresh P Vyas. Advances in Effective Vaccine Development Against Hepatitis B: Focus on Mucosal Vaccine Delivery Strategies. Therapeutic Delivery 2010; 1(3): 397 doi: 10.4155/tde.10.19
|
| 10 |
Chang-Zheng Song, Qing-Wei Wang, Chang-Cheng Song, Zeng-Liang Bai. Viral replication modulated by synthetic peptide derived from hepatitis B virus X protein. World Journal of Gastroenterology 2004; 10(3): 389-392 doi: 10.3748/wjg.v10.i3.389
|